scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0168-8278(00)80102-6 |
P8608 | Fatcat ID | release_lhgttraonvhsfmfcdjg4tiwcxq |
P698 | PubMed publication ID | 10898318 |
P50 | author | Jesús Prieto | Q28324697 |
P2093 | author name string | Sun Y | |
Qian C | |||
Peng D | |||
Barajas MA | |||
P2860 | cites work | Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors | Q24683259 |
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis | Q24684374 | ||
Parvoviridae: Second Report | Q28303662 | ||
Selective extraction of polyoma DNA from infected mouse cell cultures | Q29547500 | ||
Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ | Q33567244 | ||
Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice | Q33733749 | ||
DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors | Q34251868 | ||
Adeno-associated virus vectors | Q35305418 | ||
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector | Q35872651 | ||
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein | Q35943644 | ||
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus | Q36242842 | ||
Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector | Q36663364 | ||
Delivery of novel therapeutic agents in tumors: physiological barriers and strategies | Q38615180 | ||
Prospects for the use of adeno-associated virus as a vector for human gene therapy | Q40643988 | ||
Treatment of hepatocellular carcinoma: too many options? | Q40761519 | ||
Recombinant adeno-associated virus for the generation of autologous, gene-modified tumor vaccines: evidence for a high transduction efficiency into primary epithelial cancer cells | Q41038376 | ||
Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors | Q42525047 | ||
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors | Q43716886 | ||
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia | Q45060641 | ||
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors | Q45299117 | ||
Adeno-associated virus-mediated gene transfer into rat carotid arteries | Q45760052 | ||
Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters | Q45764253 | ||
Recombinant adeno-associated virus for muscle directed gene therapy | Q45764433 | ||
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector | Q45855552 | ||
Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide | Q45886993 | ||
The next frontier of molecular medicine: delivery of therapeutics. | Q54718920 | ||
Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin | Q67254517 | ||
Hepatocellular carcinoma | Q67494896 | ||
Radiation enhancement of radiolabelled antibody deposition in tumors | Q69447389 | ||
High-performance liquid chromatography determination of 4'-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene beta-D-glucopyranoside) (VP 16-213) in human plasma | Q70730673 | ||
Barriers to drug delivery in solid tumors | Q72141985 | ||
Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma | Q73106027 | ||
Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle | Q73254110 | ||
High-performance liquid chromatography of etoposide in plasma and urine | Q93575971 | ||
P433 | issue | 6 | |
P921 | main subject | genotoxicity | Q1009245 |
P304 | page(s) | 975-985 | |
P577 | publication date | 2000-06-01 | |
P1433 | published in | Journal of Hepatology | Q15724402 |
P1476 | title | Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents | |
P478 | volume | 32 |
Q36308321 | Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model |
Q37285005 | Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma |
Q40023775 | Augmented transgene expression in transformed cells using a parvoviral hybrid vector |
Q36948324 | Bioelectronome. Integrated approach to receptor chemistry, radicals, electrochemistry, cell signaling, and physiological effects based on electron transfer |
Q34097306 | Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles |
Q36458554 | Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells |
Q39031877 | Effect and mechanism of Mitomycin C combined with recombinant adeno-associated virus type II against glioma |
Q35010189 | Effects of augmentation of liver regeneration recombinant plasmid on rat hepatic fibrosis |
Q34482357 | Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies |
Q35208038 | Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact |
Q33970439 | Recombinant adenoassociated virus in cancer gene therapy |
Q39122342 | Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma. |
Q34729878 | Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model |
Q34804660 | Self-complementary AAV vectors; advances and applications |
Q40678035 | Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice |
Q26772315 | Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma |
Q24655262 | Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model |
Q30442929 | Topoisomerase inhibition accelerates gene expression after adeno-associated virus-mediated gene transfer to the mammalian heart |
Q36623130 | Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector |